Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Chaperonin containing TCP1 subunit 6 pseudogene 1 (CCT6P1) is a human gene annotated as a pseudogene, most likely arising from duplication of the CCT6 gene but rendered non-functional by mutations. It does not encode any protein and is not associated with any known biological functions, disease associations, or molecular interactions. Pseudogenes like CCT6P1 serve as evolutionary remnants and are not considered relevant molecular targets for therapeutic or diagnostic purposes[1][4][7]. Summary of critical points: - CCT6P1 is a pseudogene, not a protein-coding gene[1][4][7]. - Not a therapeutic target—does not encode functional protein[1][7]. - No known biological roles, drug interactions, or disease links[1][4][7]. - Frequently confused with CCT6A or CCT6B, which are functional subunits of the CCT/TRiC complex that acts as a molecular chaperone[2][3][6][9][10]. - If you are seeking data on functional chaperonin subunits relevant to human biology, refer to CCT6A ("Chaperonin containing TCP1 subunit 6") rather than CCT6P1. CCT6P1 should be excluded from structured drug target lists and biological analyses.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Chaperonin containing TCP1 subunit 6 pseudogene 1 (CCT6P1).